Matthew J. Ferris, MD
Medical Director, Maryland Proton Treatment Center; Associate Professor of Radiation Oncology
Dr. Ferris’ areas of interest at the University of Maryland is focused on optimizing advanced radiation techniques, including proton therapy, to maximize control of malignancies while sparing side effects and improving long-term patient reported outcomes. His research has resulted in numerous peer-reviewed publications and has yielded oral presentations at national and international conferences. He also has keen interest in clinical trial development and enrollment.
Overall, Dr. Ferris strives to work closely with the entire treatment team, including surgeon and medical oncology colleagues, to offer cutting edge and tailored treatment for each patient. He prizes meticulousness and attention to detail throughout each patient’s course of radiation therapy.
Special Interests: Head and Neck cancers, Thoracic cancers and Skin cancers
Medical Degree: University of Maryland School of Medicine
Residency: Emory University
Certification: Radiation Oncology
To learn more about Dr. Ferris, please view the video below.
Education and Training
- Undergraduate: Loyola University Maryland, 2010
- Medical School: University of Maryland School of Medicine, 2014
- Internship: Emory University, 2015
- Residency: Emory University, 2019
Biosketch
Dr. Matthew J. Ferris is an Associate Professor in the Department of Radiation Oncology at the University of Maryland. He works primarily at Maryland Proton Treatment Center, where he serves as Medical Director. He is a member of the University of Maryland Medical System head and neck, thoracic (lung), and skin cancer multidisciplinary care teams.
Dr. Ferris grew up in Towson, MD. He completed his undergraduate studies in 2010 at Loyola University Maryland where he majored in Biology, with minors in Business and English. He was elected a member of the Phi Beta Kappa Society. He graduated from the University of Maryland Medical School in 2014, and there was elected as a member of the Alpha Omega Alpha Honor Medical Society.
In 2015 he completed a medical internship at Emory University in Atlanta, Georgia, and then he continued on at Emory for residency training in radiation oncology, which concluded in 2019. He served as Chief Resident during his final year of training.
His research has resulted in numerous peer-reviewed publications and has yielded oral presentations at national and international conferences. He serves on national level committees for head and neck and lung cancer. Dr. Ferris’ ongoing research at the University of Maryland is focused on optimizing advanced radiation techniques to maximize control of malignancies while sparing side effects and improving long-term patient reported outcomes.
Overall, Dr. Ferris strives to work closely with the entire treatment team, including surgeon and medical oncology colleagues, to offer cutting edge and tailored treatment for each patient. He prizes meticulousness and attention to detail throughout each patient’s course of radiation therapy.
In his spare time he enjoys surfing, golfing, hunting, and spending time with his wife and three children.
Research/Clinical Keywords
General Radiation Oncology, Stereotactic Radiosurgery (SRS), Stereotactic Body Radiation Therapy (SBRT), Oligometastatic Disease, High Dose Rate, Brachytherapy, Proton Beam Therapy
Highlighted Publications
• MJ Ferris, KS Martin, JM Switchenko, OA Kayode, J Wolf, Q Dang, RH Press, WJ Curran, and KA Higgins. Sparing cardiac substructures with optimized volumetric modulated arc therapy and intensity-modulated proton therapy in thoracic radiation for locally advanced non-small cell lung cancer. Practical Radiation Oncology 2019. E-pub ahead of print, April 2019.
doi: https://doi.org/10.1016/j.prro.2019.04.013
• MJ Ferris, Y Liu, J Ao, J Zhong, M Abugideiri, TW Gillespie, BC Carthon, MA Bilen, O Kucuk, and AB Jani. The addition of chemotherapy in the definitive management of high-risk prostate cancer. Urologic Oncology 2018; 36(11).
doi: 10.1016/j.urolonc.2018.07.020
• MJ Ferris, R Jiang, M Behera, S Ramalingam, WJ Curran, and KA Higgins. Radiation therapy is associated with an increase in incidence of cardiac events for patients with small-cell lung cancer. Int J Radiat Oncol Biol Phys (Red Journal) 2018; 102: 383 – 390.
doi: 10.1016/j.ijrobp.2018.05.066
• MJ Ferris, J Zhong, JM Switchenko, KA Higgins, RJ Cassidy, MW McDonald, BR Eaton, KR Patel, CE Steuer, HM Baddour Jr, AH Miller, DW Bruner, C Xiao, and JJ Beitler. Brainstem dose is associated with patient-reported acute fatigue in head and neck cancer radiotherapy. Radiotherapy and Oncology (Green Journal) 2018; 126: 100-106.
doi: 10.1016/j.radonc.2017.08.008
